ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,060Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 113

$595K Total Retail Price of All Prescriptions

Rank: 16 out of 113

615 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
17% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 615 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

8% of this provider’s 615 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 11,281 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
LISINOPRIL 523 516 1 3
SIMVASTATIN 498 496 2 2
LEVOTHYROXINE SODIUM 470 439 3 1
HYDROCHLOROTHIAZIDE 447 424 4 9
FUROSEMIDE 413 375 5 6
OMEPRAZOLE 409 373 6 5
ATORVASTATIN CALCIUM 405 389 7 15
AMLODIPINE BESYLATE 341 340 8 4
WARFARIN SODIUM 323 308 9 8
LOSARTAN POTASSIUM 285 276 10 13
ATENOLOL 280 276 11 16
POTASSIUM CHLORIDE 255 233 12 12
SERTRALINE HCL 251 232 13 21
METFORMIN HCL 247 229 14 11
METOPROLOL SUCCINATE 228 226 15 10
PRAVASTATIN SODIUM 189 170 16 23
ZOLPIDEM TARTRATE 184 163 17 19
METOPROLOL TARTRATE 176 175 18 14
HYDROCODONE-ACETAMINOPHEN 176 166 S3 18 7
TRIAMTERENE-HCTZ 164 163 20 26
DIGOXIN 141 138 21 27
GEMFIBROZIL 133 133 22 61
SPIRONOLACTONE 130 120 23 32
PAROXETINE HCL 121 111 24 45
GABAPENTIN 120 107 25 18
DONEPEZIL HCL 107 107 26 33
OXYBUTYNIN CHLORIDE 104 96 27 89
CITALOPRAM HBR 101 87 28 17
CARVEDILOL 98 98 29 25
TRAMADOL HCL 97 95 30 29
FLUTICASONE PROPIONATE 95 94 31 39
TAMSULOSIN HCL 80 80 32 24
ALLOPURINOL 80 80 32 20
DOXAZOSIN MESYLATE 76 76 34 49
FLUOXETINE HCL 76 61 34 31
PREDNISONE 72 46 36 28
LANTUS 72 68 36 38
CRESTOR 72 72 36 30
NAMENDA 69 69 39 48
KLOR-CON 10 69 69 39 68
NEXIUM 67 60 41 47
CLOPIDOGREL 66 65 42 56
MIRTAZAPINE 65 59 43 71
ESCITALOPRAM OXALATE 63 58 44 86
DIOVAN 63 63 44 42
ADVAIR DISKUS 61 49 46 35
CELEBREX 60 59 47 90
PLAVIX 59 59 48 81
FAMOTIDINE 57 53 49 71
ISOSORBIDE MONONITRATE ER 56 56 50 82
TRAZODONE HCL 56 56 50 41
GLIMEPIRIDE 52 52 52 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 27, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.